At-Home Self-Collection Device for Cervical Cancer Screening Gets FDA Approval
Teal Health has received FDA approval for the Teal Wand, a prescription-based self-collection device for cervical cancer screening.
Teal Health has received FDA approval for the Teal Wand, a prescription-based self-collection device for cervical cancer screening.
Fellow Health showcased innovative research, emphasizing mail-in semen testing to enhance prostate cancer diagnostics and PVSA care.
A new high-sensitivity troponin test from Siemens can diagnose heart attacks but also predicts a patient’s risk of future cardiac events.
Liquid biopsy is a groundbreaking, non-invasive method for early cancer detection and monitoring, offering significant clinical potential.
The Oropouche virus, once thought rare, is now recognized as widely underdiagnosed in Latin America, and needs more research.
hc1 has launched HerCare, a new module in its MyBloodHealth platform, to enhance maternal health by providing real-time lab-driven insights.
One-Sentence Summary:Beckman Coulter Life Sciences has launched a next-generation Basophil...
Researchers have successfully adapted high-field NMR-based lipoprotein analysis to cost-effective benchtop NMR systems.
Researchers have identified the key enzyme causing Alzheimer’s disease by linking it to excessive GABA production in reactive astrocytes.
A study highlights that premature menopause significantly increases the risk of Type 2 diabetes, emphasizing the need for early detection.
A new review highlights the critical role of lncRNAs in the development, diagnosis, and treatment of acute kidney injury (AKI) and CKD.
The Cystic Fibrosis Base assay has received IVDR accreditation, ensuring high standards for detecting cystic fibrosis mutations.
Vail Scientific, in partnership with Minnetronix, has unveiled a newly designed VSNO sepsis screening device that enhances usability.